Does proximal location of culprit lesion confer worse prognosis in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction?

Journal of Interventional Cardiology

Volumn 19, Issue 4, 2006, Pages 285-294

  Harjai, Kishore J ^a   Mehta, Rajendra H ^b   Stone, Gregg W ^c   Boura, Judy A ^d   Grines, Lorelei ^d   Brodie, Bruce R ^e   Cox, David A ^f   O'Neill, William W ^d   Grines, Cindy L ^d  

^a GUTHRIE RESEARCH INSTITUTE   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c Department of Medicine   (United States)

^d WILLIAM BEAUMONT HOSPITAL   (United States)

^e LeBauer Health Care   (United States)

^f Mid Carolina Cardiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB;

ADULT; ANGIOGRAPHY; ANGIOPLASTY; ARTICLE; BLOOD CLOT LYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART INFARCTION; HEART VENTRICLE ARRHYTHMIA; HOSPITALIZATION; HUMAN; HYPOTENSION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT ELEVATION; ST SEGMENT ELEVATION HEART MUSCLE INFARCTION; STENT; TREATMENT OUTCOME;

AGED; ANALYSIS OF VARIANCE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CONFOUNDING FACTORS (EPIDEMIOLOGY); CORONARY ANGIOGRAPHY; CORONARY STENOSIS; FEMALE; FOLLOW-UP STUDIES; HEART CONDUCTION SYSTEM; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 33746913092     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2006.00146.x     Document Type: Article

References (28)

1. Christian TF, Schwartz RS, Gibbons RJ. Determinants of infarct size in reperfusion therapy for acute myocardial infarction. Circulation 1992;86:81-90.
2. Bruce CJ, Christian TF, Schaer GL, et al. Determinants of infarct size after thrombolytic treatment in acute myocardial infarction. Am J Cardiol 1999;83:1600-1605.
3. Arnold AE, Simoons ML. 'Expected infarct size without thrombolysis,' a concept that predicts immediate and long-term benefit from thrombolysis for evolving myocardial infarction. Eur Heart J 1997;18:1736-1748.
4. Huber KC, Bresnahan JF, Bresnahan DR, et al. Measurement of myocardium at risk by technetium-99m sestamibi: Correlation with coronary angiography. J Am Coll Cardiol 1992;19:67-73.
5. Klarich KW, Christian TF, Higano ST, et al. Variability of myocardium at risk for acute myocardial infarction. Am J Cardiol 1999;83:1191-1195.
6. Bates ER, Califf RM, Stack RS, et al. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI-1) trial: Influence of infarct location on arterial patency, left ventricular function and mortality. J Am Coll Cardiol 1989;13:12-18.
7. Karha J, Murphy SA, Kirtane AJ, et al. Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarction. Am J Cardiol 2003;92:913-918.
8. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1993;328:673-679.
9. Stone GW, Marsalese D, Brodie BR, et al. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI-II) Trial Investigators. J Am Coll Cardiol 1997;29:1459-1467.
10. Grines CL, Marsalese DL, Brodie B, et al. Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. PAMI-II Investigators. Primary Angioplasty in Myocardial Infarction. J Am Coll Cardiol 1998;31:967-972.
11. Stone GW, Brodie BR, Griffin JJ, et al. Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: In-hospital and 30-day results of the PAMI Stent Pilot Trial. Primary Angioplasty in Myocardial Infarction Stent Pilot Trial Investigators. J Am Coll Cardiol 1998;31:23-30.
12. Esente P, Kaplan AV, Ford JK, et al. Local intramural heparin delivery during primary angioplasty for acute myocardial infarction: Results of the Local PAMI Pilot Study. Catheter Cardiovasc Interven 1999;47:237-242.
13. Grines CL, Cox DA, Stone GW, et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1999;341:1949-1956.
14. Grines CL, Westerhausen DR Jr, Grines LL, et al.Arandomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: The Air Primary Angioplasty in Myocardial Infarction study. J Am Coll Cardiol 2002;39:1713-1719.
15. Wharton TP Jr, Grines LL, Turco MA, et al. Primary angioplasty in acute myocardial infarction at hospitals with no surgery on-site (the PAMI-No SOS study) versus transfer to surgical centers for primary angioplasty. J Am Coll Cardiol 2004;43:1943-1950.
16. O'Keefe JH Jr, Grines CL, DeWood MA, et al. Factors influencing myocardial salvage with primary angioplasty. J Nucl Cardiol 1995;2:35-41.
17. Ishihara M, Sato H, Tateishi H, et al. Intraaortic balloon pumping as the postangioplasty strategy in acute myocardial infarction. Am Heart J 1991;122:385-389.
18. Ohman EM, George BS, White CJ, et al. Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The Randomized IABP Study Group. Circulation 1994;90:792-799.
19. van 't Hof AW, Liem AL, de Boer MJ, et al. A randomized comparison of intra-aortic balloon pumping after primary coronary angioplasty in high risk patients with acute myocardial infarction. Eur Heart J 1999;20:659-665.
20. Christiansen JP, Liang CS. Reappraisal of the Norris score and the prognostic value of left ventricular ejection fraction measurement for in-hospital mortality after acute myocardial infarction. Am J Cardiol 1999;83:589-591, A8.
21. Corpus RA, House JA, Marso SP, et al. Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction. Am Heart J 2004;148:493-500.
22. Stone GW, Cox D, Garcia E, et al. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: Analysis from the primary angioplasty in myocardial infarction trials. Circulation 2001;104:636-641.
23. Jaski BE, Cohen JD, Trausch J, et al. Outcome of urgent percutaneous transluminal coronary angioplasty in acute myocardial infarction: Comparison of single-vessel versus multivessel coronary artery disease. Am Heart J 1992;124:1427-1433.
24. Gibson CM, de Lemos JA, Murphy SA, et al. Methodologic and clinical validation of the TIMI myocardial perfusion grade in acute myocardial infarction. J Thromb Thrombolysis 2002;14:233-237.
25. Dixon SR, Whitbourn RJ, Dae MW, et al. Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction. J Am Coll Cardiol 2002;40:1928-1934.
26. Mahaffey KW, Puma JA, Barbagelata NA, et al. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: Results of a multicenter, randomized, placebo-controlled trial: The Acute Myocardial Infarction Study of Adenosine (AMISTAD) trial. J Am Coll Cardiol 1999;34:1711-1720.
27. Marzilli M, Orsini E, Marraccini P, et al. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation 2000;101:2154-2159.
28. Claeys MJ, Bosmans J, De CM, et al. Effect of intracoronary adenosine infusion during coronary intervention on myocardial reperfusion injury in patients with acute myocardial infarction. Am J Cardiol 2004;94:9-13.